Glycoprotein IIb/IIIa inhibitors for the neurointerventionalist.
| Autor: | Simonato D; Department of Neuroradiology, Oxford University Hospital NHS Foundation Trust, UK.; Institute of Radiology, University of Padova, Italy., Borchert RJ; Department of Clinical Neurosciences, University of Cambridge, UK., Labeyrie MA; Interventional Neuroradiology Unit, Lariboisiere Hospital, France., Fuschi M; Department of Neuroradiology, Oxford University Hospital NHS Foundation Trust, UK., Thibault L; WFITN Scientific Committee Member, Paris, France., Henkes H; Clinic for Neuroradiology, Klinikum Stuttgart, Stuttgart, Germany., Fiorella D; Department of Neurosurgery, Stony Brook University Hospital, New York, USA., Tan BY; Division of Neurology, National University Health System and Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Yeo LL; Division of Neurology, National University Health System and Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Makalanda HL; Royal London Hospital, London, UK., Wong K; Royal London Hospital, London, UK., Bhogal P; Royal London Hospital, London, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences [Interv Neuroradiol] 2022 Feb; Vol. 28 (1), pp. 84-91. Date of Electronic Publication: 2021 May 04. |
| DOI: | 10.1177/15910199211015038 |
| Abstrakt: | Antiplatelet therapies are commonly used in neurointerventional procedures. However, specific guidelines for their use in these settings is lacking and it can often be difficult to balance the potential risks and benefits of these medications. Considering the continued growth and adoption of neurointerventional procedures, it is crucial to understand the properties of these agents in order to use them safely. Large-scale clinical trials are still needed to clarify many of these aspects for this emerging field. However, the existing literature already provides insight into which antiplatelet drugs are of benefit to the neurointerventionalist as well as their associated risks of ischemic and hemorrhagic complications. Hence, this review focuses on the applications of GPIIb/IIIA inhibitors to neurointerventional procedures. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|